Meanwhile, thalidomide is a TNFα inhibitor that down-regulating the NFκB-iNOS pathway29, which simultaneously contributes to HPS and muscle wasting in cirrhosis. Here, NFKB1 is linked to Hermansky-Pudlak syndrome.